GRM8, a metabotropic glutamate receptor, intricately regulates glutamate neurotransmission and has established associations with various central nervous system (CNS) disorders, including major depression, schizophrenia, and autism (Li et al., 2016). This evidence concerns the gene GRM8 and major depressive disorder.